Pulmonary Pharmacology, Volume 98: Advancements in Respiratory Drug Discovery and Development

Stay updated on the latest breakthroughs in respiratory medicine with Pulmonary Pharmacology, Volume 98, expertly compiled by W. S. Fred Wong. This comprehensive volume delves into the cutting-edge research on drug discovery and development for respiratory diseases, including asthma, COPD, and pulmonary fibrosis.

Groundbreaking Topics and Therapies

• Corticosteroids, monoclonal antibodies, tyrosine kinase inhibitors, and phosphodiesterase inhibitors for treating respiratory diseases
• Novel therapeutic strategies, such as renin-angiotensin system modulators, mitochondrial function modulators, and non-antibacterial macrolides
• Senotherapy for lung ageing in respiratory diseases, exploring new possibilities
• Innovative pulmonary delivery technologies, including inhaled biologics, for enhanced treatment outcomes

Benefits for Respiratory Medicine Professionals

This authoritative volume provides:

• Accurate reviews from renowned experts in pulmonary pharmacology
• Consolidated graphical materials for effortless reading and comprehension
• Latest insights and future perspectives on drug discovery and development for respiratory diseases

Published by Elsevier Science, this seminal work is an indispensable resource for researchers, clinicians, and students in respiratory medicine, offering a deep understanding of the latest advancements in the field.

Stay ahead in respiratory medicine with Pulmonary Pharmacology, Volume 98.

Book Details:

Language: English
ISBN: 9780443188800, 9780443188817
Publication Date: August 2, 2023

Upgrade your knowledge and understanding of respiratory disease treatment and management with this authoritative resource.